Evolution Equity Partners Secures $50.8 Million Commitment from British Patient Capital for Cybersecurity Investments
Evolution Equity Partners, a specialist technology investor with a focus on cybersecurity and enterprise software companies, has received a $50.8 million commitment from British Patient Capital for its third fund. This investment comes after a $35 million commitment to Evolution’s second fund in 2020.
The investment by British Patient Capital is a testament to the UK’s leadership in cybersecurity innovation and its expertise in this valuable technology sector. The investment showcases the critical importance of cybersecurity to the safety of UK-based enterprises, governments, and consumers.
Richard Seewald, Founder and Managing Partner at Evolution Equity Partners, expressed excitement about partnering with British Patient Capital and NSSIF to support UK-based cybersecurity companies. He emphasized how this partnership will provide these companies with capital, knowledge, tools, and strategies to drive performance and success in the global market.
Robert Greenwood, Investment Director of Funds at British Patient Capital, highlighted the evolution of cybersecurity over the last two decades. He emphasized how cybersecurity has become a crucial application across all sectors as businesses strive to protect themselves, their customers, and their products. This investment underscores the necessity of next-generation technology that can defend and protect society and our way of life.
